We are live on
!
Find out more
WA1
Wimmer Associates 1 Portfolio holdings
AUM
$205M
1-Year Est. Return
21.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.19%
1 Year Est. Return
+21.23%
3 Year Est. Return
+69.43%
5 Year Est. Return
+91.58%
10 Year Est. Return
+307.32%
AUM
$115M
AUM Growth
+$235K
(+0.21%)
Cap. Flow
-$1.7M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
31.49%
Holding
104
New
2
Increased
19
Reduced
55
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
+$674K |
| 2 |
Merck
MRK
|
+$371K |
| 3 |
Unilever
UL
|
+$209K |
| 4 |
Accenture
ACN
|
+$207K |
| 5 |
Amgen
AMGN
|
+$54.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$372K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$316K |
| 3 |
Johnson & Johnson
JNJ
|
+$302K |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$214K |
| 5 |
Corning
GLW
|
+$213K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.1% |
| 2 | Healthcare | 12.85% |
| 3 | Financials | 11.09% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 9.98% |
Similar funds
UWM
LFA
TCM
PKC
WCM
LWM
KFA
TFM
Wimmer Associates 1's Q3 2019 Portfolio in Review
As of Q3 2019, Wimmer Associates 1 held 104 positions worth $115M, up 0.21% from $114M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Wimmer Associates 1's Q3 2019 filing shows 2 new, 19 increased, 55 reduced and 5 closed positions. Its largest new stake was Unilever: 3,019 shares worth $204K. The largest sale was Novartis, an estimated $372K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Wimmer Associates 1's largest Q3 2019 buy was Unilever: 3,019 shares worth $204K.
- Wimmer Associates 1 added most to Vanguard Dividend Appreciation ETF in Q3 2019, an estimated $674K increase.
- Wimmer Associates 1's biggest Q3 2019 reduction was Johnson & Johnson, cutting an estimated $302K.
- Wimmer Associates 1 fully exited Novartis in Q3 2019, selling an estimated $372K.
- Wimmer Associates 1's ten largest holdings make up 31% of its $115M portfolio in Q3 2019.
- Wimmer Associates 1 opened 2 new positions and closed 5 in Q3 2019.
- Wimmer Associates 1's portfolio value rose 0.21% quarter-over-quarter to $115M.
Based on Wimmer Associates 1's 13F filing for Q3 2019, filed 14 Nov 2019.